1. Home
  2. STTK vs MAPS Comparison

STTK vs MAPS Comparison

Compare STTK & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$2.60

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo WM Technology Inc.

MAPS

WM Technology Inc.

HOLD

Current Price

$0.88

Market Cap

106.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
MAPS
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
106.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
MAPS
Price
$2.60
$0.88
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$4.00
$2.61
AVG Volume (30 Days)
171.3K
851.7K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$1,000,000.00
$179,305,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.43
P/E Ratio
N/A
$12.44
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$0.72
52 Week High
$2.71
$1.65

Technical Indicators

Market Signals
Indicator
STTK
MAPS
Relative Strength Index (RSI) 71.07 44.17
Support Level $1.93 $0.84
Resistance Level $2.18 $0.90
Average True Range (ATR) 0.18 0.05
MACD 0.07 0.01
Stochastic Oscillator 97.78 61.83

Price Performance

Historical Comparison
STTK
MAPS

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About MAPS WM Technology Inc.

WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.

Share on Social Networks: